Toward Improved Patient Care

Dr. David A. Targan ’95 sees therapeutic genomics as a key to more personalized and improved patient care in the future. For example, he says, pharmacogenomics, the study of how an individual’s genetic inheritance affects the body’s response to drugs, “could change the entire pharmaceutical landscape as we know it with tailor-made drugs and supplements.”

A graduate of the Philadelphia College of Osteopathic Medicine and a specialist in internal medicine at Lankenau Hospital on the Philadelphia Main Line, he founded a company dedicated to applying recent discoveries in genomics to the practice of medicine. Cellular GenetiX is spreading the word about genetic medicine with the aim of becoming the leading coordination center for information on efforts in therapeutic genomics by biotechnology companies, pharmaceutical companies, hospitals, physicians, cryopreservation facilities, genetic testing laboratories, and genetic counselors.